The molecular basis of skeletal muscle differentiation
- PMID: 8202645
The molecular basis of skeletal muscle differentiation
Abstract
In recent years, significant advances have been made in understanding the molecular mechanisms involved in the regulation of skeletal-muscle differentiation. This review focuses on the role of the MyoD family of myogenic transcription factors that includes MyoD, myf-5, myogenin, and MRF4 (herculin or myf-6) in myogenesis. Members of this family share sequence homology for the basic-helix-loop-helix (bHLH) regulatory motif. The basic domain is required for DNA binding, whereas the HLH domain is required for dimerization. The bHLH motif confers both properties of transcriptional activation of muscle specific genes and inhibition of cell growth through collaboration with the E2A gene products (E12 and E47) and the retinoblastoma gene product (pRB). The functions of the MyoD family can be suppressed through inhibition of their expression or activity by various factors. These include peptide growth factors (FGF and TGF-beta), immediate early gene products (Fos, Jun and Myc), other oncogene products (Ras, Src), the Id protein, and innervation. The use of gene-knockout animal models has shown that there is some degree of functional redundancy in that inactivation of either MyoD or myf-5 has no effect on muscle development, whereas inactivation of both genes results in an absolute lack of muscle cells. In contrast, the inactivation of myogenin alone results in mice with gross deficiency of mature muscle.
Similar articles
-
Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.Dev Biol. 1995 Nov;172(1):37-50. doi: 10.1006/dbio.1995.0004. Dev Biol. 1995. PMID: 7589813
-
Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.Dev Biol. 2000 Mar 15;219(2):287-98. doi: 10.1006/dbio.2000.9621. Dev Biol. 2000. PMID: 10694423
-
Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.Oncogene. 2003 Aug 28;22(36):5658-66. doi: 10.1038/sj.onc.1206690. Oncogene. 2003. PMID: 12944914
-
Molecular biology of myogenic regulatory factors.Mol Biol Med. 1991 Apr;8(2):185-95. Mol Biol Med. 1991. PMID: 1806761 Review.
-
Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review.Int J Dev Biol. 1996 Feb;40(1):345-53. Int J Dev Biol. 1996. PMID: 8735947 Review.
Cited by
-
Fndc5/irisin is regulated by myogenesis stage, irisin, muscle type and training.Am J Transl Res. 2022 Oct 15;14(10):7063-7079. eCollection 2022. Am J Transl Res. 2022. PMID: 36398256 Free PMC article.
-
The effect of linseed on intramuscular fat content and adipogenesis related genes in skeletal muscle of pigs.Lipids. 2009 Nov;44(11):999-1010. doi: 10.1007/s11745-009-3346-y. Epub 2009 Oct 2. Lipids. 2009. PMID: 19798528
-
Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage.Mol Cell Biol. 1997 Jul;17(7):3997-4006. doi: 10.1128/MCB.17.7.3997. Mol Cell Biol. 1997. PMID: 9199334 Free PMC article.
-
The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis.Genes Dev. 2006 Mar 15;20(6):675-88. doi: 10.1101/gad.1383706. Epub 2006 Mar 1. Genes Dev. 2006. PMID: 16510869 Free PMC article.
-
Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts.Mol Cell Biol. 2002 Jun;22(11):3875-91. doi: 10.1128/MCB.22.11.3875-3891.2002. Mol Cell Biol. 2002. PMID: 11997521 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous